Key result
Stent for Life initiative expands PPCI utilization and improves STEMI mortality across 10 countries.
Why the study?
Despite evidence supporting PPCI for STEMI, only 40-45% of European STEMI patients received PPCI in 2007, with large intercountry variation.
The Stent for Life initiative has been associated with increased utilization of primary PCI and improved STEMI mortality rates in participating European and neighboring countries.
Answers are grounded in this paper and cite their sources.
May encourage regional STEMI networks; leaves open whether initiative caused mortality gains or reflects concurrent trends.
AIMS: Primary percutaneous coronary intervention (PPCI) is the recommended treatment for patients with acute ST-segment elevation myocardial infarction (STEMI). Despite substantial evidence of its effectiveness, a 2007 study reported that only 40-45% of European STEMI patients were treated with PPCI, with large variations in treatment availability between countries. In 2008, the Stent for Life (SFL) initiative was launched by the European Association of Percutaneous Cardiovascular Interventions and EuroPCR in partnership with the European Society of Cardiology (ESC) Working Group on Acute Cardiac Care and country-specific national cardiac societies. The aim is to promote the prioritisation of percutaneous coronary intervention treatment towards those who will benefit most, namely STEMI patients. The following countries are currently participating: Bulgaria, Egypt, France, Greece, Italy, Portugal, Romania, Serbia, Spain and Turkey. METHODS AND RESULTS: Since SFL was launched, several activities have been initiated in the participating countries. Preliminary reports suggest that major increases have been seen in the numbers of PPCI performed, with some countries reporting very significant increases in PPCI use from 2008-2010. Improvements in STEMI mortality rates have also been observed. CONCLUSIONS: This report summarises the progress of the SFL initiative in the 10 target countries.
No takes yet. Share an insight, caveat, or question.
Kristensen et al. (2012) conducted a review in ST-segment elevation myocardial infarction (STEMI). Stent for Life (SFL) initiative was evaluated on Primary percutaneous coronary intervention (PPCI) use and STEMI mortality rates. The Stent for Life initiative reported major increases in primary percutaneous coronary intervention use and improvements in STEMI mortality rates across 10 participating countries from 2008 to 2010.
Synapse has enriched 10 related papers. Consider them for comparative context: